SCHEMBL9674642

SCHEMBL9674642

c1ccc2c(c1)Cc1ccnnc1-2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 1/20 0.47
▸ KDM4E B2RXH2 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ TP53 P04637 2/20 0.44
▸ CYP3A4 P08684 2/20 0.44
▸ CYP2D6 P10635 2/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ PKM P14618 2/20 0.44
▸ TSHR P16473 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ MAOA P21397 1/20 0.43
▸ MAPK8 P45983 3/20 0.42
▸ MAPK9 P45984 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23143475 0.84 CYP11B2 (0.44) KDM4EMAPTSMN1; SMN2NPC1RAB9A
SCHEMBL23143476 0.81 DRD4 (0.47) MAPTTSHRMAOACYP19A1BCHE
SCHEMBL17264315 0.78 CHRNB2 (0.37) MAOACYP19A1TNFCDK1CDK2
SCHEMBL17264314 0.76 TDP1 (0.33) KDM4EMEN1KMT2ALMNA
SCHEMBL30322896 0.75 MEN1 (0.47) METAP2KDM4EMAPTSMN1; SMN2MEN1
SCHEMBL69894 0.75 MEN1 (0.47) METAP2KDM4EMAPTSMN1; SMN2MEN1
SCHEMBL30276323 0.74 KMT2A (0.46) KDM4EMAPTSMN1; SMN2MEN1CYP2D6
SCHEMBL10735470 0.73 CA12 (0.46) METAP2HSD17B10MAPK8MAPK9MAPK10
SCHEMBL70512 0.72 METAP2 (0.47) METAP2KDM4EMAPTSMN1; SMN2MEN1
SCHEMBL7292209 0.71 KDR (0.43) SMN1; SMN2MEN1CYP2D6KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110845481-B 3,4-diazafluorene derivatives, method for synthesizing same, and electronic device containing 3,4-diazafluorene derivatives 苏州久显新材料有限公司 2023-04-18 — — CN claimed
CN-110845481-A 3, 4-diazafluorene derivatives, method for synthesizing the same, and electronic devices containing the same 苏州久显新材料有限公司 2020-02-28 — — CN claimed
CN-102002003-A Class I diazafluorenone, fluorene and spiro-fluorene derivative, and preparation method and application thereof UNIV EAST CHINA NORMAL 2011-04-06 — — CN claimed
CN-110845481-B 3,4-diazafluorene derivatives, method for synthesizing same, and electronic device containing 3,4-diazafluorene derivatives 苏州久显新材料有限公司 2023-04-18 — — CN disclosed
CN-110845481-B 3,4-diazafluorene derivatives, method for synthesizing same, and electronic device containing 3,4-diazafluorene derivatives 苏州久显新材料有限公司 2023-04-18 — — CN disclosed
CN-110845481-B 3,4-diazafluorene derivatives, method for synthesizing same, and electronic device containing 3,4-diazafluorene derivatives 苏州久显新材料有限公司 2023-04-18 — — CN disclosed
CN-110845481-A 3, 4-diazafluorene derivatives, method for synthesizing the same, and electronic devices containing the same 苏州久显新材料有限公司 2020-02-28 — — CN disclosed
CN-110845481-A 3, 4-diazafluorene derivatives, method for synthesizing the same, and electronic devices containing the same 苏州久显新材料有限公司 2020-02-28 — — CN disclosed
CN-110845481-A 3, 4-diazafluorene derivatives, method for synthesizing the same, and electronic devices containing the same 苏州久显新材料有限公司 2020-02-28 — — CN disclosed
CN-102002003-A Class I diazafluorenone, fluorene and spiro-fluorene derivative, and preparation method and application thereof UNIV EAST CHINA NORMAL 2011-04-06 — — CN disclosed
US-5153211-A Enzyme inhibitors ALCON LABORATORIES, INC. (US) 1992-10-06 — — US disclosed
US-5070100-A COMPLICATIONS OF DIABETES ALCON LABORATORIES, INC. (US) 1991-12-03 — — US disclosed
US-4864028-A ANTIDIABETIC AGENTS ALCON LABORATORIES, INC. (US) 1989-09-05 — — US disclosed
US-4537892-A ANTIDIABETIC AGENTS ALCON LABORATORIES, INC. (US) 1985-08-27 — — US disclosed
EP-0137333-A2 Spiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductase ALCON LABORATORIES, INC. (US) 1985-04-17 — — EP disclosed
Send feedback